Quick Takeaways
- MAK Capital Fund LP filed SCHEDULE 13G for ClearPoint Neuro, Inc. Common Stock, $0.01 par value per share (CLPT).
- Disclosed ownership: 6.1%.
- Date of event: 10 Mar 2026.
MAK Capital Fund LP - 10 Mar 2026 SCHEDULE 13G Report for ClearPoint Neuro, Inc. Common Stock, $0.01 par value per share (CLPT)
- Filing Manager
- MAK Capital Fund LP
- Reporting Manager
- MAK Capital Fund LP
- Symbol
- CLPT
- Shares outstanding
- 28,354,279 shares
- Disclosed Ownership
- 1,729,611 shares
- Ownership
- 6.1%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Mar 2026, 16:34:01 UTC
- Date of event
- 10 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"MAK Capital Fund LP disclosed 6.1% ownership in ClearPoint Neuro, Inc. Common Stock, $0.01 par value per share (CLPT) on 10 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Mar 2026, 16:34.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| MAK Capital Fund LP | 6.1% | 1,729,611 | 0 | 1,729,611 | /s/ Michael A. Kaufman | Managing Member | |
| MAK CAPITAL ONE LLC | 6.1% | 1,729,611 | 0 | 1,729,611 | /s/ Michael A. Kaufman | Managing Member | |
| Kaufman Michael A | 6.1% | 1,729,611 | 0 | 1,729,611 | /s/ Michael A. Kaufman | Michael A. Kaufman |